-
- Yorifuji Tohru
- Division of Pediatric Endocrinology and Metabolism, Children’s Medical Center, Osaka City General Hospital, Osaka, Japan
-
- Horikawa Reiko
- Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo, Japan
-
- Hasegawa Tomonobu
- Department of Pediatrics, Keio University, Tokyo, Japan
-
- Adachi Masanori
- Department of Endocrinology and Metabolism, Kanagawa Children’s Medical Center, Kanagawa, Japan
-
- Soneda Shun
- Department of Pediatrics, St. Marianna University School of Medicine, Kanagawa, Japan
-
- Minagawa Masanori
- Division of Endocrinology, Chiba Children’s Hospital, Chiba, Japan
-
- Ida Shinobu
- Department of Pediatric Gastroenterology, Nutrition and Endocrinology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan
-
- Yonekura Takeo
- Department of Pediatric Surgery, Nara Hospital, Kindai University Faculty of Medicine, Nara, Japan
-
- Kinoshita Yoshiaki
- Department of Pediatric Surgery, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
-
- Kanamori Yutaka
- Department of Surgery, National Center for Child Health and Development, Tokyo, Japan
-
- Kitagawa Hiroaki
- Division of Pediatric Surgery, St. Marianna University School of Medicine, Kanagawa, Japan
-
- Shinkai Masato
- Department of Surgery, Kanagawa Children’s Medical Center, Kanagawa, Japan
-
- Sasaki Hideyuki
- Department of Pediatric Surgery, Tohoku University, Miyagi, Japan
-
- Nio Masaki
- Department of Pediatric Surgery, Tohoku University, Miyagi, Japan
この論文をさがす
説明
<p>Congenital hyperinsulinism is a rare condition, and following recent advances in diagnosis and treatment, it was considered necessary to formulate evidence-based clinical practice guidelines reflecting the most recent progress, to guide the practice of neonatologists, pediatric endocrinologists, general pediatricians, and pediatric surgeons. These guidelines cover a range of aspects, including general features of congenital hyperinsulinism, diagnostic criteria and tools for diagnosis, first- and second-line medical treatment, criteria for and details of surgical treatment, and future perspectives. These guidelines were generated as a collaborative effort between The Japanese Society for Pediatric Endocrinology and The Japanese Society of Pediatric Surgeons, and followed the official procedures of guideline generation to identify important clinical questions, perform a systematic literature review (April 2016), assess the evidence level of each paper, formulate the guidelines, and obtain public comments.</p>
収録刊行物
-
- Clinical Pediatric Endocrinology
-
Clinical Pediatric Endocrinology 26 (3), 127-152, 2017
日本小児内分泌学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204485046656
-
- NII論文ID
- 130005865516
-
- ISSN
- 13477358
- 09185739
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可